000			03654nam a2200445 c4500
999			_c7353 _d7353
001			7353
003			ES-MaUEC
005			20200714194746.0
006			a||||fo|||| 00| 0
007			cr nn nnnanaaa
008			190730s2019 gw a o |||| 0|eng d
020			_a9783030222581
024	7		_a10.1007/978-3-030-22258-1 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-VaUE
050		4	_aRC280 _b.I58 2019 EB
245	0	0	_aIntrahepatic Cholangiocarcinoma : _bDiagnosis and Management _cedited by Timothy M. Pawlik, Jordan M. Cloyd, Mary Dillhoff.
250			_a1st ed. 2019.
264		1	_aCham _bSpringer International Publishing : _bImprint: Springer _c2019.
300			_a1 recurso en línea (XI, 215 páginas) _b 35 ilustraciones, 25 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_atext file _bPDF
490	0		_aMedicine (Springer-11650)
505	0		_aEpidemiology and Risk Factors -- Clinical Presentation and Diagnosis -- Staging and Prognosis -- Imaging -- Surgical Treatment -- Management of the Nodal Basin -- Pathologic Assessment -- Systemic Therapy -- Percutaneous Ablation -- Transarterial Therapies -- Radiotherapy -- Molecular Pathogenesis: From Inflammation And Cholestasis To A Microenvironment-Driven Tumor -- Clinical Trials and Novel/Emerging Treatment.
520	3		_aThis book provides a comprehensive review of the epidemiology, molecular pathogenesis, diagnosis and treatment of intrahepatic cholangiocarcinoma (ICC). It brings together an impressive group of international experts in cholangiocarcinoma research and clinical care. The book was organized and written to aid the clinician's understanding of emerging research in cholangiocarcinoma and its application to the clinical care of patients with ICC. Each chapter details the scientific evidence to support clinical decisions that are needed to care for these complex patients. Focused chapters detail the epidemiology, diagnostic evaluation, as well as staging and prognosis of this disease. In addition to dedicated chapters on surgical management of ICC, a broad emphasis on locoregional therapies, including percutaneous ablation and transarterial therapies, is included. An up-to-date overview of the molecular pathogenesis and pathological assessment of ICC is detailed prior to chapters focusing on systemic chemotherapy and emerging novel therapy options. Intrahepatic Cholangiocarcinoma is not only an invaluable resource for many as they seek to provide the best multidisciplinary cancer care to patients with ICC, but also an opportunity to identify new avenues of scientific discovery that lead to significant advances in the diagnosis and management of ICC.
988			_aSegundosemestre_2019_Medicine
650		7	_aConductos biliares _9671436 _2embne _xCáncer
700	1		_aPawlik, Timothy M _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt _987925
700	1		_aCloyd, Jordan M _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aDillhoff, Mary _eeditor _4edt _4http://id.loc.gov/vocabulary/relators/edt
710	2		_aSpringerLink (Online service) _9106937
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783030222574
776	0	8	_iPrinted edition: _z9783030222598
776	0	8	_iPrinted edition: _z9783030222604
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-22258-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942			_2lcc _cLE
998			_db _feng _ggw _h0 _zSI